Recombinant zoster vaccine offers better value, protection against shingles

Disclosure: This site contains some affiliate links. We might receive a small commission at no additional cost to you.

Written & Supervised By
Preventive Medicine and Public Health Specialist | 40+ Years Experience

Medically Reviewed
Dr. Jose Rossello, MD, PhD, MHCM
Preventive Medicine & Public Health Specialist
Last Reviewed: February 21, 2019

February 18, Vaccination with the recombinant zoster vaccine demonstrated higher cost-effectiveness and prevention of herpes zoster, compared with live zoster vaccine and no vaccination, according to research published in Annals of Internal Medicine .

Read the source article at Healio[1]

author avatar
Jose Rossello, MD, PhD, MHCM
Dr. Rossello is a medical doctor specializing in Preventive Medicine and Public Health. He founded PreventiveMedicineDaily.com to provide evidence-based health information supported by authoritative medical research.
See Full Bio
Previous
Next
Leave a Comment

Your email address will not be published. Required fields are marked

{"email":"Email address invalid","url":"Website address invalid","required":"Required field missing"}